MIAN
TEVA icon

Mariner Independent Advisor Network’s Teva Pharmaceuticals TEVA Stock Holding History

Mariner Independent Advisor Network’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17,468
Closed -$173K – 525
2021
Q2 		$173K Sell
17,468
-125
-0.7% -$1.32K 0.01% 488
2021
Q1 		$203K Buy
+17,593
New +$202K 0.01% 428
2020
Q3 		– Sell
-24,909
Closed -$286K – 342
2020
Q2 		$286K Buy
+24,909
New +$282K 0.03% 295

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Mariner Independent Advisor Network's TEVA Position: Q3 2021 in Review

Mariner Independent Advisor Network sold out of Teva Pharmaceuticals (TEVA) in Q3 2021, closing a stake of 17,468 shares — an estimated $173K sold.

Mariner Independent Advisor Network first reported a position in TEVA in Q2 2020 and held it in 3 quarters. The position peaked at $286K in Q2 2020. 429 funds tracked by Wall St. Rank hold TEVA as of Q3 2021.

  • Mariner Independent Advisor Network reported no remaining Teva Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Mariner Independent Advisor Network sold 17,468 Teva Pharmaceuticals shares in Q3 2021, an estimated $173K.
  • Mariner Independent Advisor Network first reported a position in Teva Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • Mariner Independent Advisor Network's Teva Pharmaceuticals position peaked at $286K in Q2 2020.
  • 429 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2021.

Based on Mariner Independent Advisor Network's 13F filing for Q3 2021, filed 17 Nov 2021.